Lon Cardon - 19 Dec 2022 Form 4 Insider Report for Mirum Pharmaceuticals, Inc. (MIRM)

Role
Director
Signature
/s/ Jody Howe, Attorney-in-Fact
Issuer symbol
MIRM
Transactions as of
19 Dec 2022
Net transactions value
$0
Form type
4
Filing time
19 Dec 2022, 20:26:48 UTC
Next filing
14 Jun 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MIRM Stock Option (right to buy) Award $0 +34,000 $0.000000 34,000 19 Dec 2022 Common Stock 34,000 $18.00 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares vest in equal annual installments over a three year period such that the option is fully vested on the third anniversary of the date of grant (December 19, 2022).